首页|Research progress on COVID-19 combined with digestive system diseases

Research progress on COVID-19 combined with digestive system diseases

扫码查看
The corona virus disease 2019 (COVID-19) is an acute respiratory infection caused by the binding of SEVERE acute respiratory syndrome coronavirus 2 (SARS-COV-2) and the angiotensin-converting enzyme 2 (ACE2) receptor to the host target organ. New research suggests that COVID-19 may be a systemic infectious disease and a systemic inflammatory disease.Symptoms and signs of the digestive system are often found in patients with coVID-19 following acute infection.At present, despite the existence of some coronavirus-related digestive diseases (such as gastrointestinal diseases, liver injury, pancreatic injury, etc.), the pathogenesis of COVID-19 with digestive symptoms in existing studies is still unclear, and relevant guidelines and expert consensus are not enough for clinical diagnosis and treatment. Therefore, it is extremely important to understand the clinical manifestations, pathogenesis and prognosis of coVID-19 patients with digestive system.

COVID-19SARS-CoV-2ACE2 receptorDigestive system

Shan-Shan Liu、Li-Ting Zheng、Yin-Nan Kang、You-Cheng Xie、Gang-Gang Jia、Jiu-Cong Zhang、Xiao-Hui Yu

展开 >

The First Clinical Medical School,Gansu University of Chinese Medicine,Lanzhou 730000,China

Department of Gastroenterology,The 940 Hospital of Joint Service Support Forces of the Chinese People's Liberation Army,Lanzhou 730050,China

Lanzhou University,Lanzhou 730000,China

940th Hospital Intra-Hospital Fund ProjectGeneral Project of Huoshenshan Hospital Scientific Research FundGansu Provincial Department of Science and Technology Social Development Department Clinical Medical Research Center Project

20yjky020HSS-21721JR7RA017

2022

海南医科大学学报(英文版)

海南医科大学学报(英文版)

ISSN:
年,卷(期):2022.28(10)
  • 2